Ginkgo Bioworks DNA Loans Receivable Fair Value Disclosure
Loans Receivable Fair Value Disclosure at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:LoansReceivableFairValueDisclosure.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's loans receivable fair value disclosure.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's loans receivable fair value disclosure?
- Ginkgo Bioworks (DNA) reported loans receivable fair value disclosure of $500K in Q4 2025.
- How has Ginkgo Bioworks's loans receivable fair value disclosure changed year-over-year?
- Ginkgo Bioworks's loans receivable fair value disclosure decreased by 96.5% year-over-year, from $14.2M to $500K.